ArticleCancer biology & therapy2013

Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells.

Michel D Wissing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.